Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRECISION BIOSCIENCES INC Director's Dealing 2026

Jan 22, 2026

34491_dirs_2026-01-22_d7194f85-a127-4152-8b01-730a229136cb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2026-01-20

Reporting Person: Kelly John Alexander (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2026-01-20 Common Stock M 3888 Acquired 81186 Direct
2026-01-20 Common Stock M 13900 Acquired 95086 Direct
2026-01-20 Common Stock M 26575 Acquired 121661 Direct
2026-01-21 Common Stock S 15213 $4.03 Disposed 106448 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2026-01-20 Restricted Stock Units $ M 3888 Disposed Common Stock (3888) Direct
2026-01-20 Restricted Stock Units $ M 13900 Disposed Common Stock (13900) Direct
2026-01-20 Restricted Stock Units $ M 26575 Disposed Common Stock (26575) Direct

Footnotes

F1: Represents the vesting of Restricted Stock Units ("RSUs") on January 20, 2026.

F2: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

F3: The sales were effected pursuant to a Rule 10b5-1 plan adopted on January 17, 2025. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.

F4: On January 20, 2023 the Reporting Person was granted RSUs, which vested in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F5: On April 18, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F6: On August 22, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.